Found 412 hits.
|
207. |
Kocatürk, E.+, Abrams, E. M., Maurer, M., Mitri, J., Oppenheimer, J., Vestergaard, C., and Zein, J.: COVID-19 and its impact on common diseases in the allergy clinics. J. Allergy Clin. Immunol. Pract. 2023: 11; 3289-3303. IF: 8.20 |
r.207
| 152(a) | Maurer, M. Rosén, K.+, and Hsie, H. J.: Comment on Omalizumab for chronic urticaria. New Engl. J. Med. 2013: 368; 2527-2530 |
|
584. |
Staubach, P.+, Bilo, B., Fluhr, J. W., Krause, K., Kulthanan, K., Salman, A., Katelaris, C., Bernstein, J. A., Maurer, M., and Mann, C.: UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities. J. Dermatol. Treat. 2024: 35; 2329784. IF: TBD (IF 2023: 2.90) |
o.584
|
585. |
Daci, D., Altrichter, S.+, Grillet, F., Dib, S., Mouna, A., Kumar, S. S., Terhorst-Molawi, D., Maurer, M., Günzel, D., and Scheffel, J.+: Altered sweat composition due to changes in tight junction expression of sweat glands in cholinergic urticaria patients. Int. J. Mol. Sci. 2024: 25; 4658. IF: TBD (IF 2023: 4.90) |
o.585
|
597. |
Pyatilova, P., Hackler, Y., Aulenbacher, F., Asero, R., Bauer, A., Bizjak, M., Day, C., Dissemond, J., Du-Thanh, A., Fomina, D., Giménez-Arnau, A., Grattan, C., Gregoriou, S., Hawro, T., Kasperska-Zajac, A., Khoshkhui, M., Kocatürk, E., Kovalkova, E., Kulthanan, K., Kuznetsova, E., Makris, M., Mukhina, O., Pesqué, D., Peter, J., Salameh, P., Siebenhaar, F., Sikora, A., Staubach, P., Tuchinda, P., Zamłyński, M., Weller, K., Maurer, M., and Kolkhir, P.+: Non-skin-related symptoms are common in chronic spontaneous urticaria and linked to active and uncontrolled disease: results from CURE. J. Allergy Clin. Immunol. Pract. 2024: 12; 1890-1899. IF: TBD (IF 2023: 8.20) |
o.597
| 114 | Maurer, M.: Effect of omalizumab on thyroid function and autoantibody levels in patients with chronic spontaneous urticaria. Comment on: Monitoring of thyroid function in patients who exhibit IgE against thyreoperoxidase on Omalizumab. J. Allergy Clin. Immunol. 2012: 129; 270. IF: 11.00 |
|
519. |
Zhu, C.*, Fok, J., Lin, L.+, Su, H.+*, and Maurer, M.: Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab. JAAD Case Rep. 2023: 32; 109-112. IF: N/A |
o.519
|
524. |
Kolkhir, P., Laires, P. A., Salameh, P., Asero, R., Bizjak, M., Košnik, M., Dissemond, J., van Doorn, M., Hawro, T., Kasperska-Zajac, A., Zajac, M., Kocatürk, E., Peter, J., Parisi, C. A. S., Ritchie, C. A., Kulthanan, K., Tuchinda, P., Fomina, D., Kovalkova, E., Khoshkhui, M., Kouzegaran, S., Papapostolou, N., Du-Thanh, A., Kamegashira, A., Meshkova, R., Vitchuk, A., Bauer, A., Grattan, C., Staubach, P., Bouillet, L., Giménez-Arnau, A. M., Maurer, M., and Weller, K.+: The benefit of complete response to treatment in patients with chronic spontaneous urticaria – CURE results. J. Allergy Clin. Immunol. Pract. 2023: 11; 610-620. IF: 8.20 |
o.524
|
44. |
Kolkhir, P. and Maurer, M.: Chronic spontaneous urticaria and comorbidities. In: Zuberbier, T. Grattan, C., and Maurer, M., editors: Urticaria and Angioedema. 2nd ed., Switzerland: Springer, 2021 |
bc.44
| 13 | Prodeus, A., Zhou, X., Maurer, M. Galli, S. J., and Carroll, M. C.+: Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 1997: 390; 172-175. IF: 27.36 |
o.013